Validation of a simplified comorbidity evaluation predicting clinical outcomes among patients with coronavirus disease 2019 – A multicenter retrospective observation studyObservational Study Published on 2022-06-012022-10-04 Journal: The American journal of emergency medicine [Category] COVID19(2023년), SARS, 임상, [키워드] Accuracy addition Admissions CCI changed Charlson Comorbidity Index chronic condition clinical Clinical outcome clinical outcomes Comorbidity coronavirus disease COVID COVID-19 COVID-19 outbreak COVID-19 pandemic COVID-19 patient COVID-19 severity Department Emergency enrolled hospital in-hospital mortality independent risk factor intensive care invasive mechanical logistic regressions multicenter observation Outbreaks Pandemic outbreaks. Patient percentage performed positive predict receiving retrospective risk SARS-CoV-2 PCR test tested three group validation was used [DOI] 10.1016/j.ajem.2022.03.011 PMC 바로가기 [Article Type] Observational Study
Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19Research article Published on 2022-06-012022-10-05 Journal: International Journal of Infectious Diseases [Category] 바이오마커, [키워드] Admission analyzed C-reactive protein chronic clinical Clinical outcome clinical outcomes correlation COVID-19 demographic data demonstrated determine elevated Evidence group groups hospital hospitalized patient ICU in-hospital mortality inclusion criteria intensive care Kaplan-Meier analysis Laboratory logistic regression model Mortality multivariable objective Patient patients hospitalized PCT Physiology procalcitonin Prognosis Result role severity significantly statistical were used with COVID-19 [DOI] 10.1016/j.ijid.2022.03.044 [Article Type] Research article
Clusters of inflammation in COVID-19: descriptive analysis and prognosis on more than 15,000 patients from the Spanish SEMI-COVID-19 RegistryCOVID-19의 염증 클러스터: 스페인 SEMI-COVID-19 레지스트리의 15,000명 이상의 환자에 대한 설명 분석 및 예후Observational Study Published on 2022-06-012022-09-11 Journal: Internal and Emergency Medicine [Category] COVID19(2023년), MERS, SARS, 바이오마커, 임상, [키워드] Analysis characteristic characterized Cluster cluster analysis Clusters coronavirus COVID-19 COVID-19 infection CRP D-dimer defined Descriptive analysis elevated Factor ferritin group hierarchical cluster analysis highest Hospital admission Hospital mortality in-hospital mortality independent Inflammation LDH lymphopenia Mortality observational study Patient Primary outcome Prognosis prognostic registry retrospective seriously ill patients Spanish uncontrolled worse prognosis [DOI] 10.1007/s11739-021-02924-4 PMC 바로가기 [Article Type] Observational Study
Routine laboratory parameters, including complete blood count, predict COVID-19 in-hospital mortality in geriatric patients전체 혈구 수를 포함한 일상적인 실험실 매개변수는 노인 환자의 COVID-19 병원 내 사망률을 예측합니다Article Published on 2022-06-012022-09-12 Journal: Mechanisms of ageing and development [Category] MERS, 바이오마커, 진단, [키워드] adjusted age Ancona baseline Blood C-reactive protein CCI clinical Comorbidity complete blood count confounders COVID-19 Cox regression criteria death Deceased enrolled eosinophil evaluate frailty Gender highest hospital Hospitalized IL-6 In-hospital in-hospital mortality increased risk independent Italy laboratory biomarker Laboratory parameters Lymphocyte count lymphopenia Mortality neutrophil Neutrophil-to-lymphocyte ratio NLR NT-proBNP older patients parameters Patient patients predict Predictive predictor procalcitonin reduce routine scale selected significantly significantly increased Support survived [DOI] 10.1016/j.mad.2022.111674 PMC 바로가기 [Article Type] Article
Treatments, resource utilization, and outcomes of COVID-19 patients presenting to emergency departments across pandemic waves: an observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN)Observational Study Published on 2022-06-012022-10-04 Journal: CJEM [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI 95% confidence interval Admission advance Care Characteristics collected data Coronavirus 2019 coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient criteria Critical care Department discharge discharged disease severity Efficiency eligible Emergency English enrolled French health system hospital hospitalisation Hospitalization ICU admissions in-hospital mortality invasive Invasive mechanical ventilation less mechanical ventilation Mortality network nous Odds ratio outcome outcomes pandemic pandemic waves. Patient patient outcomes patients presenting Primary outcome Rapid reductions in regression modeling remained resource Resource utilization response retrospective SARS-CoV-2 second wave secondary severe COVID-19 therapy treatment strategy Ventilation [DOI] 10.1007/s43678-022-00275-3 PMC 바로가기 [Article Type] Observational Study
Call, chosen, HA 2 T 2, ANDC: validation of four severity scores in COVID-19 patientsObservational Study Published on 2022-06-012022-10-04 Journal: Infection [Category] COVID19(2023년), SARS, 임상, [키워드] acute respiratory syndrome age analysed Analysis association AUC Care Cohort Complete coronavirus COVID-19 COVID-19 patient death defined Disease progression external validation hospitalised ICU admission in-hospital mortality Infection invasive ventilation males management Mortality negative NPV Patient patients with COVID-19 polymerase chain Predictive primary endpoint risk Risk scores SARS-CoV-2 secondary endpoint Severity Score significantly Switzerland validation validation study [DOI] 10.1007/s15010-021-01728-0 PMC 바로가기 [Article Type] Observational Study
High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trialRandomized Controlled Trial Published on 2022-05-272022-10-05 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 임상, [키워드] 1:1 95% CI Admission age assessment assigned baseline block Complication conducted Controlled clinical trial COVID-19 diabete Disease progression dose double-blind enrolled evaluate failure group high oral dose highest hospital Hospital stay Hospitalized hospitalized patient hospitals in-hospital mortality Infection intensive care matching placebo median Mild-to-moderate multicentre no significant difference not significantly different oral vitamin D3 outcome participant patients Placebo placebo group placebo-controlled clinical trial Prevent Primary outcome Randomized recorded risk factor Risk factors SARS-CoV-2 secondary Serious Adverse Event stratified with COVID-19 women worsening [DOI] 10.1371/journal.pone.0267918 PMC 바로가기 [Article Type] Randomized Controlled Trial
Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysisMeta-Analysis Published on 2022-05-272023-07-06 Journal: European journal of preventive cardiology [Category] COVID19(2023년), [키워드] cardiovascular disease COVID-19 in-hospital mortality Meta-analysis [DOI] 10.1093/eurjpc/zwab119 PMC 바로가기 [Article Type] Meta-Analysis
The Influence of Maternal Factors on Neonatal Intensive Care Unit Admission and In-Hospital Mortality in Premature Newborns from Western Romania: A Population-Based StudyObservational Study Published on 2022-05-262022-10-05 Journal: Medicina [Category] 임상, [키워드] accelerate Admission advanced age affecting age Antibiotics Care cause Characteristics contributed COVID-19 pandemic death death rate demographic data determine develop European Evolution Factor global public health Health services Hospitalization In-hospital in-hospital mortality Infant Infection influence intensive care intensive care unit less likelihood material Maternal morbidity Mortality Neonatal neonatal intensive care unit Neonatal Mortality Neonate Neonates Newborn NICU admission objective obstetrics outcome pandemic Patient Pregnancy Premature premature birth Prematurity required resource Result Retrospective study risk factor Risk factors Romania significant difference significantly statistically significant Steroids Support sustainable development goal therapy understanding union variable while [DOI] 10.3390/medicina58060709 PMC 바로가기 [Article Type] Observational Study
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses코로나19 입원 환자를 위한 렘데시비르 및 기타 3가지 약물: WHO 연대 무작위 시험의 최종 결과 및 업데이트된 메타 분석Meta-Analysis Published on 2022-05-212022-09-11 Journal: Lancet (London, England) [Category] 신약개발, 임상, 치료제, [키워드] 1:1 allocation Analysis antiviral drugs assigned average both groups Characteristics Compliance controls country COVID-19 COVID-19 diagnosis database death died discharge discharged disease severity drug drugs eligible patient Endpoint enrolled exclusion Final futility hospital Hospital mortality hospitalised hospitalised patient Hospitalised patients Hydroxychloroquine in both groups in-hospital mortality Inpatient Inpatients interferon ISRCTN Kaplan-Meier Local Lopinavir meta-analyses Meta-analysis Mortality mortality analysis mortality rate ratio no significant effect occurred Open-label outcome oxygen participant Patient patients patients with COVID-19 Placebo placebos primary endpoint progressed progression proportion randomisation Randomised trial Randomly rate ratio receive recruited regions Registered Remdesivir reported secondary Secondary endpoints solidarity Solidarity trial Standard of care study drug the WHO treatment period Trial Ventilated Ventilation were given WHO [DOI] 10.1016/S0140-6736(22)00519-0 PMC 바로가기 [Article Type] Meta-Analysis